| Deal Information |
|
||||
| Credit & Investment Research |
|
||||
| Market Research |
|
||||
| News |
|
||||
Valeant Pharmaceuticals Intl acquires InterMune Inc-Infergen rights from InterMune Inc
|
US - Valeant Pharmaceuticals International acquired the United States and Canadian rights to the hepatitis C drug Infergen of InterMune Inc, a developer of innovative products for the treatment of pulmonary diseases, for $### mil. The consideration was to consist of…
|
|
Copyright © 2012 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.